Target hematologic values in the management of essential thrombocythemia and polycythemia vera.
about
Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617FAnagrelide hydrochloride and ruxolitinib for treatment of polycythemia vera.Management of side effects of BCR/ABL-negative chronic myeloproliferative neoplasm therapies. Focus on anagrelide.Application of prognostic score IPSET-thrombosis in patients with essential thrombocythemia of a Brazilian public service.Influence of platelet and white blood cell counts on major thrombosis - analysis from a patient registry in essential thrombocythemia.
P2860
Target hematologic values in the management of essential thrombocythemia and polycythemia vera.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Target hematologic values in t ...... ythemia and polycythemia vera.
@en
type
label
Target hematologic values in t ...... ythemia and polycythemia vera.
@en
prefLabel
Target hematologic values in t ...... ythemia and polycythemia vera.
@en
P2860
P356
P1476
Target hematologic values in t ...... cythemia and polycythemia vera
@en
P2093
Montse Gómez
P2860
P356
10.1111/EJH.12381
P577
2014-05-29T00:00:00Z